HIV PRE-EXPOSURE PROPHYLAXIS
Clinical trials for HIV PRE-EXPOSURE PROPHYLAXIS explained in plain language.
Never miss a new study
Get alerted when new HIV PRE-EXPOSURE PROPHYLAXIS trials appear
Sign up with your email to follow new studies for HIV PRE-EXPOSURE PROPHYLAXIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Monthly pill could revolutionize HIV prevention
Prevention CompletedThis study tested a new once-monthly pill, MK-8527, to see if it is safe and how it works in people at low risk for HIV. 352 adults took either the pill or a placebo. The main goal was to check for side effects and how the drug moves through the body.
Matched conditions: HIV PRE-EXPOSURE PROPHYLAXIS
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Prevention
Last updated May 15, 2026 11:55 UTC
-
Breast milk drug study aims to protect infants
Knowledge-focused CompletedThis study looked at how a drug called MK-8527 moves into breast milk after a single dose. 13 healthy women who were at least 6 weeks postpartum took part. Researchers measured the amount of drug in breast milk over 120 hours to understand how much a baby might receive. The goal …
Matched conditions: HIV PRE-EXPOSURE PROPHYLAXIS
Phase: PHASE1 • Sponsor: Merck Sharp & Dohme LLC • Aim: Knowledge-focused
Last updated May 14, 2026 12:04 UTC